Values are mean + SEM. (n=5 per group). bP<0.05 significantly different from control, abP<0.05 significantly different from the diabetic group treated with glibenclamide and amlodipine and adP<0.05 significantly different from the untreated diabetic group. C: Normal saline group K: Potassium adapted group G: Glibenclamide treated group A: Amlodipine treated group AG: Group treated with amlodipine and glibenclamide D: Diabetic group DG: Diabetic group treated with glibenclamide DGA: Diabetic group treated with glibenclamide and amlodipine KDG: Potassium adapted diabetic group treated with glibenclamide KDGA: Potassium adapted diabetic group treated with glibenclamide and amlodipine

Figure 1: Effect of K+ adaptation on blood glucose of streptozotocin induced diabetic rats treated with amlodipine and glibenclamide.

Goto home»